Premium
Withdrawn: Effectiveness and safety of toripalimab, camrelizumab and sintilimab in a real‐world cohort of hepatitis B virus associated hepatocellular carcinoma patients
Author(s) -
Yuan Guosheng,
Hu Xiaoyun,
Li Qi,
Dai Wencong,
Cheng Xiao,
Ying Pengfei,
Yu Wenxuan,
Guo Yabing,
Chen Mian,
Chen Jinzhang
Publication year - 2020
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14452
Subject(s) - hepatocellular carcinoma , cohort , medicine , cohort study , oncology , family medicine , pharmacology